lysosomal storage disease
Let an agent explain lysosomal storage diseases as a group, relay classification, mechanisms and treatments from medical references in general terms, route people with symptoms or diagnoses to specialists and patient organisations, and distinguish lysosomal disorders from other inborn errors of metabolism.
Bundle → Layer → Finding → Questions Filled
4 bundles · 8 layers · 8 findings · 16 questions
Understand What these diseases are.
Definition
Definition and mechanism.
Definition
Definition.
- What are lysosomal storage diseases, and how do enzyme deficiencies cause storage? definition
- Is the user asking about their own or a family member s diagnosis, which needs a specialist? boundary
Groups
Subgroups.
Groups
Groups.
- What are the sphingolipidoses, mucopolysaccharidoses, sialic acid disorders and other subgroups? definition
- Which entry fits the specific disorder? action
Care Diagnosis and treatment.
Diagnosis
Diagnosis.
Diagnosis
Diagnosis.
- How are these disorders diagnosed with enzyme assays, genetics and newborn screening, in general terms? provenance
- Which references are standard? provenance
Treatment
Treatment.
Treatment
Treatment.
- What treatments exist, from enzyme replacement to substrate reduction and gene therapy, as reported? provenance
- Which sources are cited? provenance
Support Support.
Organisations
Patient organisations.
Organisations
Organisations.
- Where can families find patient organisations and specialist centres? action
- Which entry fits rare disease organisations? action
Genetics
Inheritance.
Genetics
Genetics.
- How are these disorders inherited, and what is genetic counselling, in general terms? provenance
- Is the user seeking personal counselling, which needs a professional? boundary
Context Research and history.
Research
Research.
Research
Research.
- What research directions exist, with findings attributed? provenance
- Which entry fits gene therapy? action
History
History.
History
History.
- How were lysosomes and these disorders discovered, from de Duve to enzyme therapy? provenance
- Which entry fits lysosome? action
Classifiers Filled
- Family
- Thing Registry
- Category
- Cross-cutting context
- Entry kind
- thing
- Plane
- XCT
- Domain
- XCT.STA
- Other names and narrower kinds
- cephalin lipidosis, lysosomal storage disease with skeletal involvement, neutral lipid storage disease, lysosomal acid phosphatase deficiency, lipid storage disease, disorder of sialic acid metabolism, neutral lipid storage myopathy, lysosomal and lipase deficiency
What it is Filled
A group of about 70 inherited metabolic disorders caused by deficient lysosomal enzymes or transport proteins, leading to accumulation of undegraded substrates in cells, including lipid storage diseases such as Gaucher, Niemann-Pick and Fabry disease, mucopolysaccharidoses with skeletal involvement, disorders of sialic acid metabolism, lysosomal acid phosphatase deficiency and historical categories such as cephalin lipidosis; many are treated with enzyme replacement, substrate reduction or transplantation, and people affected should be under the care of specialists. Neutral lipid storage disease involves cytoplasmic lipid droplets and is not a lysosomal storage disease.
Why it exists Filled
Let an agent explain lysosomal storage diseases as a group, relay classification, mechanisms and treatments from medical references in general terms, route people with symptoms or diagnoses to specialists and patient organisations, and distinguish lysosomal disorders from other inborn errors of metabolism.
Distinguishing features Filled
- Lysosomal enzyme deficiency
- Substrate accumulation
- Mostly recessive
- Treatable subset
What robots and AI may and may not do Filled
Must not
- Diagnose a person or child from described symptoms.
- Recommend or discourage a specific enzyme replacement or other treatment for a person.
- Present outdated treatment information as current.
- Disclose a person's or family's genetic diagnosis without consent.
Only with a human decision
- Decisions about testing, treatment or family planning.
May
- Describe lysosomal storage diseases and their main groups in general terms.
- Point people to genetic counselling, specialist centres and patient organisations.
Moral aspects Filled
- These rare diseases often go undiagnosed for years; misinformation adds to the delay.
- Genetic diagnoses affect whole families and can lead to discrimination.
Who is affected
- Patients and families
- Carriers
- Rare disease clinicians
Owners Filled
Steward
The patient owns their diagnosis; clinicians and rare disease registries hold the records.
Master systems
- Rare disease patient registries
Links to other meta-models Filled
parent
- Q1496114 - registry parent class
related
- overload disease - in registry terms
- inborn error of metabolism - in general terms
- Gaucher disease - the most common
- enzyme replacement therapy - for several disorders
What else AI and robots need to interact with it Filled
Identity and identifiers required Filled
- Vercy registry: vr.tr.lysosomal-storage-disease
- Wikidata: Q675010 (https://www.wikidata.org/wiki/Q675010)
- ICD-10: E75-E77 disorders of sphingolipid and glycoprotein metabolism
- MeSH: D016464 Lysosomal Storage Diseases
Direct properties not applicable Not applicable
- known disorders: about 70 count
- combined incidence: about 1 in 5000 births - estimates
- first enzyme replacement therapy: 1991 year - Gaucher disease
Plane XCT: no invented physical properties.
Recognition optional Filled
- These are inherited disorders of lysosomal breakdown.
- Examples include Gaucher disease, Fabry disease, Niemann-Pick disease, mucopolysaccharidoses, lysosomal sialic acid disorders and lysosomal acid phosphatase deficiency.
- Other inborn errors affect mitochondria, peroxisomes or cytosolic pathways, while neutral lipid storage disease involves cytoplasmic lipid droplets rather than lysosomal storage.
- Not a visible object; clinical features vary by disorder.
Capabilities and actions required Filled
- explain the group and mechanism
- relay classification and treatments
- route to specialists
- distinguish related disorders
Hazards and failure modes required Filled
- Diagnostic delay
- Agents giving personal medical advice
- Stale treatment information
Standards and interfaces required Filled
- Orphan drug regulations
- Newborn screening programmes in some regions
- Clinical guidelines for specific disorders
Context of use required Filled
- Not applicable; a disease group.
- sphingolipidoses such as Gaucher, Fabry and Niemann-Pick
- mucopolysaccharidoses with skeletal involvement
- glycoproteinoses and sialic acid disorders
- lipid storage diseases including neutral lipid storage disease
- lysosomal acid phosphatase deficiency and rare enzyme deficiencies
- lysosomal transport defects
Sources Filled
- Wikidata item Q675010: lysosomal storage disease - identity and sense of the item
- Wikipedia: Lysosomal storage disease - general description of the item
Open questions
- Should individual disorders be the primary linked entries?
- How should medical references be linked?
- The registry entry has merged aliases naming subgroups and historical terms; should they be split off?
Machine files
Provenance
thing registry research (pass 2) · unreviewed
Built from: models/things/publications/thing-q675010/spec.json